ARCHIVES

Low-Dose IFN Not Effective Against Melanoma, Study Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013

Sen. Mack Calls For “National Crusade” Against Cancer.

May 26, 2000

Howard Hughes Medical Institute Seeks up to 25 New Researchers

January 17, 2014

New NIH Grant Program or Young Investigators

October 8, 2010

FDA Encourages Study Of Gender Differences

August 6, 1993

New Publications

January 20, 1989